期刊文献+

1-取代-β-咔啉衍生物的设计、合成与初步的抗肿瘤作用研究(英文) 被引量:1

Design and synthesis of 1-substituted-β-carboline derivatives as potential anticancer agents
原文传递
导出
摘要 为了寻找高效低毒的抗肿瘤候选化合物,我们对β-咔啉环的1,2,9三个结构位点进行了设计与合成,得到了一系列的1-取代-β-咔啉衍生物,这些化合物的结构经~1H NMR、^(13)C NMR、MS、IR及元素分析确证。采用四甲基偶氮唑盐(MTT)法考察了目标化合物体外抗肿瘤(Bel-7402,HepG2,A549,A375,786-0和HT-29)活性,构效关系结果显示β-咔啉1位取代基团对抗肿瘤活性的影响趋势为:2-噻吩基>2-氯苯基>4-氯苯基>苄基。 In the present study, we designed and synthesized a series of 1-substituted-β-carboline derivatives through modification of position-l, 2 and 9 of β-carboline nucleus in order to discover novel leading compounds with better antitumor activities and less toxicity. Their structures were confirmed by 1H NMR, 13C NMR, MS, IR and elemental analyses. All the target compounds were tested for cytotoxic activity against six cancer cell lines, including Bel-7402, HepG2, A549, A375, 786-0 and HT-29 by methyl thiazolyl tetrazolium (MTT) method. Studies of structure-activity relationships indicated that the effects of substituents in position- 1 on cytotoxic activities were in an order as follows: 2-thienyl 〉2-chlorophenyl 〉4-chlorophenyl 〉benzyl group.
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2015年第12期801-808,共8页 中国药学(英文版)
基金 National Science and Technology Major Projec of the Ministry of Science and Technology of China(Grant No2011ZX09401-007) National Key Technology Research and Development Program of the Ministry of Science and Technology of China(Grant No.2012BAI30B00)
关键词 β-咔啉 合成 抗肿瘤活性 构效关系 β-Carboline, Synthesis, Anticancer activity, Structure-activity relationships
  • 相关文献

参考文献32

  • 1Allen, J.R.F.; Holmstedt, B.R. Phytochemistry. 1980, 19, 1573-1582.
  • 2Kusurkar, R.S.; Alkobati, N.A.H.; Gokule, A.S.; Puranik, V.G. Tetrahedron. 2008, 64, 1654-1662.
  • 3Liu, J.W.; Cui, G.H.; Zhao, M.; Cui, C.Y.; Ju, J.F.; Peng, S.Q. Bioorg. Ailed. Chem. 2007, 15, 7773-7778.
  • 4Liu, J.W.; Wu, G.F.; Cui, G.H.; Wang, W.X.; Zhao, M.; Wang, C.; Zhang, Z.D.; Peng, S.Q. Bioorg. Med. Chem. 2007, 15, 5672-5693.
  • 5Saha, B.; Sharma, S.; Sawant, D.; Kundu, B. Tetrahedron Lett. 2007, 48, 1379-1383.
  • 6Zhao, M,; Bi, L.; Wang, W.X.; Wang, C.; Baudy, F.M.; Ju, J.F.; Peng, S.Q. Bioorg. Med. Chem. 2006, 14, 6998- 7010.
  • 7Ashok, P.; Chander, S.; Balzarini, J.; Pannecouque, C.; Murugesan, S. Bioorg. Med. Chem. Lett. 2015, 25, 1232- 1235.
  • 8Chen, Y.F.; Lin, Y.C.; Chen, J.P.; Chan, H.C.; Hsu, M.H.; Lin, H.Y.; Kuo, S.C.; Huang, L.J. Bioorg. Med. Chem. Lett. 2015, 25, 3873-3877.
  • 9Shankaraiah, N.; Siraj, K.P.; Nekkanti, S.;Srinivasulu, V.; Sharma, P.; Senwar, K.R.; Sathish, M.; Vishnuvardhan, M.V.P.S.; Rarnakrishna, S.; Jadala, C.; Nagesh, N.; Kamal, A. Bioorg. Chem. 2015, 59, 130-139.
  • 10Chauhana, S.S.; Singh, A.K.; Meena, S.; Lohani, M.; Singh, A.; Arya, R.K.; Cheruvu, S.H.; Sarkar, J.; Gayen, J. R.; Datta, D.; Chauhan, P.M.S. Bioorg. Med. Chem. Left. 2014, 24, 2820-2824.

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部